Loading...

About Us

We believe in a diverse range of personnel to bring creative skills, thoughts, and ideas to the table.

Our History

Apellis was founded in 2009. Apellis’ approach is centered on the inhibition of the complement system, which is a cascade of interacting proteins and is an integral component of the immune system. We have developed our lead product candidates, which are analogs of the cyclic peptide compstatin, based on technology that we have exclusively licensed from the Trustees of the University of Pennsylvania. Our lead compounds are designed to broadly inhibit complement C3, the central protein in the complement cascade. Under conditions of excessive or uncontrolled activation, the complement system plays a key role in a wide range of autoimmune and inflammatory diseases. We believe that by inhibiting the complement system at C3 we may effectively control these diseases. In addition, we believe that C3 inhibition may potentially correct the underlying immunological dysfunction that characterizes many of these diseases, an approach we refer to as complement immunotherapy.

Our Team

Cedric Francois

Cedric Francois, MD/PhD

CO-FOUNDER &
CHIEF EXECUTIVE OFFICER/PRESIDENT
Pascal Deschatelets

Pascal Deschatelets, PhD

CO-FOUNDER &
CHIEF OPERATING OFFICER
Robert Kim

Robert Y. Kim, MD

CHIEF MEDICAL OFFICER
Steven Axon

Steven Axon

CHIEF BUSINESS OFFICER
Daniel Geffken

Daniel Geffken

INTERIM
CHIEF FINANCIAL OFFICER
David Watson

David Watson, JD

GENERAL COUNSEL &
VICE-PRESIDENT OF CORPORATE DEVELOPMENT
Federico Grossi

Federico Grossi, MD/PhD

VICE-PRESIDENT
OF CLINICAL DEVELOPMENT
Stephen Judd

Stephen Judd

VICE-PRESIDENT
OF PRODUCT & COMMERCIAL DEVELOPMENT
Ahmad Sadr

Ahmad Sadr

VICE-PRESIDENT
OF TECHNICAL OPERATIONS
Nicole Perry

Nicole Perry, CPA

VICE-PRESIDENT
OF FINANCE
Monica Gerber

Monica Gerber, MD/PhD/JD

VICE-PRESIDENT
OF INTELLECTUAL PROPERTY

Board of Directors

Gerald Chan

Gerald Chan, SD

CHAIRMAN
Bihua Chen

Bihua Chen

DIRECTOR
Cedric Francois

Cedric Francois, MD/PhD

CO-FOUNDER
& CHIEF EXECUTIVE OFFICER/PRESIDENT

Scientific Advisory Board

Peter Hillmen

Peter Hillmen,
MD, PhD.

PNH SCIENTIFIC
ADVISORY BOARD
Robert A. Brodsky

Robert A. Brodsky,
MD.

PNH SCIENTIFIC
ADVISORY BOARD
Jaroslaw Maciejewski

Jaroslaw Maciejewski,
MD, PhD, FACP

PNH SCIENTIFIC
ADVISORY BOARD
Jason S. Slakter

Jason S. Slakter,
MD.

AMD SCIENTIFIC
ADVISORY BOARD
Philip J. Rosenfeld

Philip J. Rosenfeld,
MD, PhD.

AMD SCIENTIFIC
ADVISORY BOARD
Johanna M. Seddon

Johanna M. Seddon,
MD, ScM.

AMD SCIENTIFIC
ADVISORY BOARD
Janet S. Sunness

Janet S. Sunness,
MD.

AMD SCIENTIFIC
ADVISORY BOARD
Gabriel J. Coscas

Gabriel J. Coscas,
MD.

AMD SCIENTIFIC
ADVISORY BOARD
Mike Yeadon

Mike Yeadon,
PhD.

PULMONOLOGY SCIENTIFIC
ADVISORY BOARD
Carl Atkinson

Carl Atkinson,
PhD.

PULMONOLOGY SCIENTIFIC
ADVISORY BOARD
Dave Singh

Dave Singh,
MD.

PULMONOLOGY SCIENTIFIC
ADVISORY BOARD
Toby Maher

Toby Maher,
MD, PhD.

PULMONOLOGY SCIENTIFIC
ADVISORY BOARD
Marsha Wills-Karp

Marsha Wills-Karp,
PhD.

PULMONOLOGY SCIENTIFIC
ADVISORY BOARD
Bruno Crestani

Bruno Crestani,
MD, PhD.

PULMONOLOGY SCIENTIFIC
ADVISORY BOARD
Claudia Kemper

Claudia Kemper,
PhD.

PULMONOLOGY, AMD AND PNH
SCIENTIFIC ADVISORY BOARD
Susan M. Lea

Susan M. Lea,
PhD.

PULMONOLOGY, AMD AND PNH
SCIENTIFIC ADVISORY BOARD